Our project will create a network to develop personalized treatments for patients with GN and identify new ways of detecting high-risk GN.
To do this, we will build upon an established research program to develop a collaborative national patient-centered program. We will expand a successful clinical database structure so it is available to the Canadian research community. We will study strategies for GN treatment that are tailored to a patient’s individual needs. We will look for specific genes and proteins that can help predict disease progression and whether an individual will benefit from innovative treatments.
Once the infrastructure is ready and the protocol approved, we will begin recruitment of 350 patients with GN. Patients enrolled in our study will be seen every six months for blood tests and updates regarding their health and well-being.
- Better research: The infrastructure we are are creating will expand the capacity for GN research in Canada and help drive innovations that will make a difference in patients’ lives.
- Better treatments: Early effective treatments for GN are important. They can stop the progression of GN, prevent kidney failure, and reduce the burden of these diseases – both for the individual and for our society as a whole.